{"id":9791,"date":"2022-09-26T11:52:01","date_gmt":"2022-09-26T11:52:01","guid":{"rendered":"https:\/\/preprod.oxypharm.net\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/"},"modified":"2025-04-28T09:35:54","modified_gmt":"2025-04-28T09:35:54","slug":"pr-alain-sarasin-forschungsdirektor-am-cnrs","status":"publish","type":"post","link":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/","title":{"rendered":"Pr. Alain Sarasin, Forschungsdirektor am CNRS"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<blockquote><p>In einem Labor, dessen Aufgabe es ist, Krebsrisiken zu analysieren, war es keine gute Idee, Material zu verwenden, das als selbst krebserregend war. Dies war einer der Gr\u00fcnde, warum man sich vor nunmehr 15 Jahren an Oxy&#8217;Pharm wandte.<\/p><\/blockquote>\n<p>[\/vc_column_text][vc_column_text]Pr. Alain Sarasin, Forschungsdirektor am CNRS &#8211; Leiter des Labors f\u00fcr die Diagnose bei Kinderkrankheiten (erbliche Hauterkrankung Xeroderma pigmentosum.) &#8211; Institut Gustave Roussy, Villejuif[\/vc_column_text][vc_video link=&#8221;https:\/\/www.youtube.com\/watch?v=WrHhhT6RSN4&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] In einem Labor, dessen Aufgabe es ist, Krebsrisiken zu analysieren, war es keine gute Idee, Material zu verwenden, das<\/p>\n","protected":false},"author":3,"featured_media":3054,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[131],"tags":[],"class_list":["post-9791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sie-haben-das-wort"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pr. Alain Sarasin, Forschungsdirektor am CNRS - Oxy&#039;Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr. Alain Sarasin, Forschungsdirektor am CNRS - Oxy&#039;Pharm\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text] In einem Labor, dessen Aufgabe es ist, Krebsrisiken zu analysieren, war es keine gute Idee, Material zu verwenden, das\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxy&#039;Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100065087790394\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-26T11:52:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-28T09:35:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marketing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OxyPharm\" \/>\n<meta name=\"twitter:site\" content=\"@OxyPharm\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marketing\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\"},\"author\":{\"name\":\"marketing\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8\"},\"headline\":\"Pr. Alain Sarasin, Forschungsdirektor am CNRS\",\"datePublished\":\"2022-09-26T11:52:01+00:00\",\"dateModified\":\"2025-04-28T09:35:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\"},\"wordCount\":100,\"publisher\":{\"@id\":\"https:\/\/www.oxypharm.net\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"articleSection\":[\"Sie haben das Wort!\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\",\"url\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\",\"name\":\"Pr. Alain Sarasin, Forschungsdirektor am CNRS - Oxy&#039;Pharm\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxypharm.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"datePublished\":\"2022-09-26T11:52:01+00:00\",\"dateModified\":\"2025-04-28T09:35:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage\",\"url\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"contentUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.oxypharm.net\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pr. Alain Sarasin, Forschungsdirektor am CNRS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oxypharm.net\/#website\",\"url\":\"https:\/\/www.oxypharm.net\/\",\"name\":\"Oxy&#039;Pharm\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.oxypharm.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oxypharm.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oxypharm.net\/#organization\",\"name\":\"Oxy'pharm\",\"alternateName\":\"Oxypharm\",\"url\":\"https:\/\/www.oxypharm.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg\",\"contentUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg\",\"width\":500,\"height\":500,\"caption\":\"Oxy'pharm\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=100065087790394\",\"https:\/\/x.com\/OxyPharm\",\"https:\/\/www.instagram.com\/oxy_pharm\/\",\"https:\/\/www.linkedin.com\/company\/oxy-pharm\/\",\"https:\/\/www.youtube.com\/channel\/UCwTjwWFZWcMdPPlvkTuiurw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8\",\"name\":\"marketing\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pr. Alain Sarasin, Forschungsdirektor am CNRS - Oxy&#039;Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/","og_locale":"de_DE","og_type":"article","og_title":"Pr. Alain Sarasin, Forschungsdirektor am CNRS - Oxy&#039;Pharm","og_description":"[vc_row][vc_column][vc_column_text] In einem Labor, dessen Aufgabe es ist, Krebsrisiken zu analysieren, war es keine gute Idee, Material zu verwenden, das","og_url":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/","og_site_name":"Oxy&#039;Pharm","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100065087790394","article_published_time":"2022-09-26T11:52:01+00:00","article_modified_time":"2025-04-28T09:35:54+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","type":"image\/jpeg"}],"author":"marketing","twitter_card":"summary_large_image","twitter_creator":"@OxyPharm","twitter_site":"@OxyPharm","twitter_misc":{"Written by":"marketing"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#article","isPartOf":{"@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/"},"author":{"name":"marketing","@id":"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8"},"headline":"Pr. Alain Sarasin, Forschungsdirektor am CNRS","datePublished":"2022-09-26T11:52:01+00:00","dateModified":"2025-04-28T09:35:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/"},"wordCount":100,"publisher":{"@id":"https:\/\/www.oxypharm.net\/#organization"},"image":{"@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","articleSection":["Sie haben das Wort!"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/","url":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/","name":"Pr. Alain Sarasin, Forschungsdirektor am CNRS - Oxy&#039;Pharm","isPartOf":{"@id":"https:\/\/www.oxypharm.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage"},"image":{"@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","datePublished":"2022-09-26T11:52:01+00:00","dateModified":"2025-04-28T09:35:54+00:00","breadcrumb":{"@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#primaryimage","url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","contentUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2021\/12\/professeur_alain_sarasin.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxypharm.net\/de\/pr-alain-sarasin-forschungsdirektor-am-cnrs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.oxypharm.net\/de\/"},{"@type":"ListItem","position":2,"name":"Pr. Alain Sarasin, Forschungsdirektor am CNRS"}]},{"@type":"WebSite","@id":"https:\/\/www.oxypharm.net\/#website","url":"https:\/\/www.oxypharm.net\/","name":"Oxy&#039;Pharm","description":"","publisher":{"@id":"https:\/\/www.oxypharm.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxypharm.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.oxypharm.net\/#organization","name":"Oxy'pharm","alternateName":"Oxypharm","url":"https:\/\/www.oxypharm.net\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/","url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg","contentUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg","width":500,"height":500,"caption":"Oxy'pharm"},"image":{"@id":"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100065087790394","https:\/\/x.com\/OxyPharm","https:\/\/www.instagram.com\/oxy_pharm\/","https:\/\/www.linkedin.com\/company\/oxy-pharm\/","https:\/\/www.youtube.com\/channel\/UCwTjwWFZWcMdPPlvkTuiurw"]},{"@type":"Person","@id":"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8","name":"marketing"}]}},"_links":{"self":[{"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/posts\/9791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/comments?post=9791"}],"version-history":[{"count":1,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/posts\/9791\/revisions"}],"predecessor-version":[{"id":21931,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/posts\/9791\/revisions\/21931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/media\/3054"}],"wp:attachment":[{"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/media?parent=9791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/categories?post=9791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxypharm.net\/de\/wp-json\/wp\/v2\/tags?post=9791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}